Health

Drug and Device Development Outsourcing with the Research Consulting Organization (RCO) Model, Upcoming Webinar Hosted by Xtalks

Leave a comment


The RCO is a new service partner that has emerged in response to the shifting landscape of drug and device development outsourcing.


TORONTO (PRWEB)

In this webinar, the featured speakers will showcase the success of ProPharma’s new Research Consulting Organization (RCO) model, which offers a refreshing approach to drug and device development outsourcing, addressing the challenges faced by smaller and mid-sized innovators with traditional Contract Research Organizations (CROs) that prioritize larger programs. The new RCO delivers a “3-D printed” solution for those sponsor programs that just don’t fit the mold.

The RCO is a new service partner that has emerged in response to the shifting landscape of drug and device development outsourcing. Historically, smaller and mid-sized innovators have found themselves relegated to the end of the queue, piecing together pivotal programs with the CRO’s “C” team. The RCO model offers a new degree of personalization and agility, which is not typically available with rigid CRO models, to meet this need. With smaller rare disease programs representing 40 percent of the industry’s pipeline, the “bigger-the-better” CRO trend has become incongruent with market needs. Traditional CROs are trapped in scale-based economic models, and the “need volume to make the numbers work” mindset, which often results in extraneous services being pushed to help drive appeal and boost margin.

Register for this webinar to discover a personalized approach to drug and device development outsourcing for smaller and mid-sized innovators.

Join Bryan Katz, Chief Strategy Officer/Head of Corporate Development, ProPharma; Sara Sorrentino, Executive Vice President, Business Development, ProPharma; and David Dobrowski, VP of Clinical Development and Regulatory Affairs, ABK Biomedical, for the live webinar on Monday, May 15, 2023, at 10am EDT (4pm CEST/EU-Central).

For more information, or to register for this event, visit Drug and Device Development Outsourcing with the Research Consulting Organization (RCO) Model.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com

For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

Contact:

Vera Kovacevic

Tel: +1 (416) 977-6555 x371

Email: vkovacevic@xtalks.com

Share article on social media or email:

Leave a Reply